Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistV10Suppliers.com, a United Kingdom-based online retailer, was cited for unlawfully selling unapproved and misbranded opioid drugs to U.S. consumers through its website in violation of the Federal Food, Drug, and Cosmetic Act (sections 301(a), 301(d), 301(k), 503(b), and 505(a)). The company's products lacked FDA approval and proper labeling, creating risks of contamination, counterfeit formulations, and inconsistent active ingredient amounts. The FDA emphasized that these unapproved drugs circumvented critical regulatory safeguards designed to ensure safety and effectiveness, particularly concerning given the severity of the ongoing opioid epidemic and associated public health crisis. The agency requested that the company cease all sales of unapproved and misbranded drugs to U.S. consumers.